CI
CoRegen, Inc.
SEC filingBiotechnology · Houston, TX
Amount raised$13.5Msold at filing
Total offering$13.5M
Investors in the raise1count reported to the SEC
FiledFeb 26, 2026first sale Oct 28, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jonathan W. SimonsDirector
Steve GorlinExecutive Officer, Director
Bert W. O'MalleyDirector
Suneet J. VarmaDirector
William J. Haseltine, PhD.Director
Sonja NelsonExecutive Officer
Sonal GuptaExecutive Officer
Lee J. FleisherDirector
Edward J. Benz, Jr.Director
Peter W. GelinasExecutive Officer
Executive officers, directors and promoters as listed on the Form D.